News Release

 

Back
 

AmerisourceBergen Hosts over 7,400 at the Largest Community Pharmacy Conference; Record Attendance Expected at National Healthcare Conference & Exposition

07/12/06

LAS VEGAS--(BUSINESS WIRE)--July 12, 2006--AmerisourceBergen (NYSE:ABC) today announced that it expects a record 7,400 attendees at its annual National Healthcare Conference & Exposition (NHCE) in Las Vegas, NV this week. The largest conference of its kind, AmerisourceBergen's NHCE brings together community pharmacy leaders, pharmaceutical manufacturers, health and beauty aids manufacturers, industry experts and others for a unique opportunity to discuss industry issues, complete continuing education credits, and conduct business.

"The AmerisourceBergen National Healthcare Conference & Exposition showcases our commitment to community pharmacy," commented R. David Yost, Chief Executive Officer of AmerisourceBergen. "We believe that the community pharmacist is key to the future of healthcare, and we are proud to offer programs and services dedicated to helping them improve the care they deliver to patients as well as grow their business."

AmerisourceBergen's commitment to community pharmacy extends well beyond the traditional supplier and customer relationship. "We believe our commitment to community pharmacy includes advocating on their behalf on legislative and regulatory issues at all levels," said Kurt J. Hilzinger, President and Chief Operating Officer of AmerisourceBergen. "We applaud the entrepreneurial spirit of community pharmacy, and work actively with colleges of pharmacy to promote store ownership. The future of community pharmacy is bright, and AmerisourceBergen is proud to support community pharmacists as they work on the front lines of healthcare each and every day."

About AmerisourceBergen

AmerisourceBergen (NYSE:ABC) is one of the world's largest pharmaceutical services companies serving the United States, Canada and selected global markets. Servicing both pharmaceutical manufacturers and healthcare providers in the pharmaceutical supply channel, the Company provides drug distribution and related services designed to reduce costs and improve patient outcomes. AmerisourceBergen's service solutions range from pharmacy automation and pharmaceutical packaging to pharmacy services for skilled nursing and assisted living facilities, reimbursement and pharmaceutical consulting services, and physician education. With more than $58 billion in annualized revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and employs more than 13,000 people. AmerisourceBergen is ranked #27 on the Fortune 500 list. For more information, go to www.amerisourcebergen.com.

FORWARD-LOOKING STATEMENTS

This news release may contain certain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may vary materially from the expectations contained in the forward-looking statements. Forward-looking statements may include statements addressing AmerisourceBergen's future financial and operating results and the benefits, efficiencies and savings to be derived from the Company's integration plans to consolidate its distribution network.

The following factors, among others, could cause actual results to differ materially from those described in any forward-looking statements: competitive pressures; the loss of one or more key customer or supplier relationships; customer defaults or insolvencies; changes in customer mix; supplier defaults or insolvencies; changes in pharmaceutical manufacturers' pricing and distribution policies or practices; adverse resolution of any contract or other disputes with customers (including departments and agencies of the U.S. Government) or suppliers; regulatory changes; changes in U.S. government policies (including reimbursement changes arising from the Medicare Modernization Act); further declines in the amounts of market share rebates offered by pharmaceutical manufacturers to the PharMerica long-term care business and/or the inability of the business to offset the rebate reductions that have already occurred, market interest rates; operational or control issues arising from AmerisourceBergen's outsourcing of information technology activities; the Pharmaceutical Distribution segment's ability to continue to successfully transition its business model to fee-for-service; success of integration, restructuring or systems initiatives; fluctuations in the U.S. dollar - Canadian dollar exchange rate and other foreign exchange rates; economic, business, competitive and/or regulatory developments in Canada, the United Kingdom and elsewhere outside of the United States; acquisition of businesses that do not perform as we expect or that are difficult for us to integrate or control; and other economic, business, competitive, legal, regulatory and/or operational factors affecting the business of AmerisourceBergen generally.

More detailed information about these and other risk factors is set forth in AmerisourceBergen's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for fiscal 2005.

AmerisourceBergen is under no obligation to (and expressly disclaims any such obligation to) update or alter any forward looking statements whether as a result of new information, future events or otherwise.

CONTACT: AmerisourceBergen Corporation
Michael N. Kilpatric, 610-727-7118
mkilpatric@amerisourcebergen.com

SOURCE: AmerisourceBergen Corporation

Corporate Overview

AmerisourceBergen is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel..

Learn More